Takeda’s Maribavir For Post-Transplant Cytomegalovirus Might See Split Panel Vote

 
• By Sue Sutter
Cytomegalovirus
Cytomegalovirus is a common cause of infection in post-transplant recipients. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers